Riskpilot← Back to searchSign inGet full accessAcromid AB
ABActiveOrg 5591071682StockholmGeneral medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
SEK 2K
-40% vs 2023
EBITDA margin
-199.4%
+58% vs 2023
Equity ratio
94.0%
Financial strength
Net profit 2024
SEK -4K
+58% vs 2023
| Revenue | SEK 2K | -40% |
| EBITDA | SEK -4K | +58% |
| Net profit | SEK -4K | +58% |
| Total assets | SEK 138K | -11% |
| Equity | SEK 129K | -3% |
| Employees | 0 | — |
Legal name
Acromid AB
Org number
5591071682
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
31 mars 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom hälso- och sjukvård, verksamhet inom informationsteknik som utbildning, föreläsningar och forskning. Import och export av medicinskt materiel och medicinsk informatik samt idka därmed förenlig verksamhet.
Address
Stockholm
Phone
+46762233288
Email
omid@acromid.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 78 | 115 | 4 | 2 |
| Staff expenses | — | — | −0 | — | — |
| EBITDA | −11 | 26 | 80 | −10 | −4 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −11 | 26 | 80 | −10 | −4 |
| Net financials | — | — | 0 | — | 0 |
| Profit before tax | −11 | 26 | 80 | −10 | −4 |
| Tax | −0 | −3 | −17 | — | — |
| Net profit | −11 | 23 | 63 | −10 | −4 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 54 | 102 | 187 | 155 | 138 |
| Equity | 61 | 81 | 144 | 133 | 129 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 7 | 21 | 43 | 22 | 8 |
| Total debt | 7 | 21 | 43 | 22 | 8 |
EBITDA margin
-199.4%
This company
15.8%
Market median
-1362% vs market
20202024
Equity ratio
94.0%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
-3.3%
This company
18.4%
Market median
-118% vs market
20202024
Net profit margin
-197.5%
This company
8.1%
Market median
-2538% vs market
20202024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PS Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Acromid AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Personuppgift Skyddad | Chief Executive Officer | 0 companies |